CAPA – Page 24 – Pharma.Tips

Inspection readiness untested during enforcement response – evidence pack for inspectors

Ensuring Inspection Readiness in the Face of Enforcement Response Challenges In the pharmaceutical industry, regulatory inspections are critical for ensuring compliance with Good Manufacturing Practices (GMP). When enforcement actions arise,…

Third-party oversight failure during corporate review – CAPA program design

Addressing Third-party Oversight Failures during Corporate Reviews: A Comprehensive Investigation Approach In the highly regulated pharmaceutical sector, the success of a robust quality system often hinges on effective third-party oversight…

Pre-filtration bioburden risk during aseptic processing – inspection readiness enhancement

Addressing Bioburden Risks in Pre-filtration During Aseptic Processing Aseptic processing is critical for maintaining the integrity of sterile products, but the risk of bioburden contamination during pre-filtration phases poses serious…

Management review ineffective during corporate review – how to satisfy FDA/EMA expectations

Addressing Ineffectiveness in Management Reviews During Corporate Audits to Meet FDA and EMA Criteria In the pharmaceutical sector, management reviews are integral to maintaining compliance and operational integrity. However, ineffective…

Compliance gaps not escalated during corporate review – evidence pack for inspectors

Addressing Compliance Gaps Not Escalated During Corporate Review: An Investigation Approach During corporate reviews, unaddressed compliance gaps can jeopardize regulatory standing and operational integrity. This article outlines an effective investigation…

Global SOP harmonization gaps during remediation – preventing repeat observations

Addressing Global SOP Harmonization Gaps During Remediation to Prevent Recurring Observations In the evolving landscape of pharmaceutical manufacturing, maintaining compliance with global Standard Operating Procedures (SOPs) is pivotal for regulatory…

Filter fouling during aseptic processing – inspection readiness enhancement

“`html Improving Inspection Readiness: Tackling Filter Fouling in Aseptic Processing In the realm of pharmaceutical manufacturing, filter fouling during aseptic processing has emerged as a critical concern, often leading to…

Global SOP harmonization gaps during corporate review – CAPA program design

Identifying Gaps in Global SOP Harmonization During Corporate Review: A CAPA Program Approach In a world where the pharmaceutical industry is subject to rigorous compliance standards, global SOP harmonization is…

Management review ineffective during corporate review – evidence pack for inspectors

Addressing Ineffective Management Reviews During Corporate Audits: An Evidence-Based Approach In pharmaceutical manufacturing, effective management reviews are critical for ensuring compliance with good manufacturing practices (GMP) and maintaining audit readiness.…

Management review ineffective during mock audit – preventing repeat observations

Assessing Ineffectiveness in Management Reviews during Mock Audits to Prevent Recurrences In pharmaceutical manufacturing, effective management reviews are crucial for maintaining compliance with regulatory standards and ensuring operational excellence. However,…

Flow rate variability during PPQ – sterility assurance optimization strategy

Strategies to Address Flow Rate Variability during PPQ for Enhanced Sterility Assurance Flow rate variability during Process Performance Qualification (PPQ) can pose significant risks to sterility assurance in pharmaceutical manufacturing.…

Internal audit findings ignored during remediation – preventing repeat observations

Addressing Neglected Internal Audit Findings to Prevent Recurring Observations In the highly regulated pharmaceutical environment, addressing internal audit findings is critical to maintaining compliance and ensuring operational integrity. However, numerous…